Epoxide hydrolase inhibition and Thiazolidinediones: A therapy for cardiometabolic syndrome
Scientists at the Medical College of Wisconsin and the University of California at Davis, led by Dr. John Imig and Dr. Bruce Hammock have determined the synergistic actions of inhibiting soluble epoxide hydrolase (sEH) with ...
Apr 23, 2013
1
1